GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » Cyclically Adjusted PB Ratio

Surmodics (STU:SU6) Cyclically Adjusted PB Ratio : 4.30 (As of Jun. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Surmodics Cyclically Adjusted PB Ratio?

As of today (2024-06-25), Surmodics's current share price is €38.60. Surmodics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €8.97. Surmodics's Cyclically Adjusted PB Ratio for today is 4.30.

The historical rank and industry rank for Surmodics's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:SU6' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.8   Med: 3.4   Max: 9.11
Current: 4.18

During the past years, Surmodics's highest Cyclically Adjusted PB Ratio was 9.11. The lowest was 1.80. And the median was 3.40.

STU:SU6's Cyclically Adjusted PB Ratio is ranked worse than
74.06% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.025 vs STU:SU6: 4.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Surmodics's adjusted book value per share data for the three months ended in Mar. 2024 was €7.997. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €8.97 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Surmodics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Surmodics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Cyclically Adjusted PB Ratio Chart

Surmodics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.27 4.54 6.17 3.15 3.24

Surmodics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.34 3.19 3.24 3.69 2.92

Competitive Comparison of Surmodics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Surmodics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surmodics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Surmodics's Cyclically Adjusted PB Ratio falls into.



Surmodics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Surmodics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=38.60/8.97
=4.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Surmodics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.997/131.7762*131.7762
=7.997

Current CPI (Mar. 2024) = 131.7762.

Surmodics Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.125 100.560 6.716
201409 5.632 100.428 7.390
201412 5.118 99.070 6.808
201503 6.051 99.621 8.004
201506 6.139 100.684 8.035
201509 6.324 100.392 8.301
201512 6.730 99.792 8.887
201603 6.820 100.470 8.945
201606 7.016 101.688 9.092
201609 7.207 101.861 9.324
201612 7.658 101.863 9.907
201703 7.705 102.862 9.871
201706 7.423 103.349 9.465
201709 7.147 104.136 9.044
201712 7.079 104.011 8.969
201803 6.940 105.290 8.686
201806 6.974 106.317 8.644
201809 6.947 106.507 8.595
201812 7.408 105.998 9.210
201903 7.566 107.251 9.296
201906 7.783 108.070 9.490
201909 8.238 108.329 10.021
201912 8.165 108.420 9.924
202003 8.310 108.902 10.056
202006 8.498 108.767 10.296
202009 8.138 109.815 9.765
202012 7.982 109.897 9.571
202103 8.606 111.754 10.148
202106 8.426 114.631 9.686
202109 8.567 115.734 9.754
202112 8.655 117.630 9.696
202203 8.649 121.301 9.396
202206 8.455 125.017 8.912
202209 7.804 125.227 8.212
202212 7.168 125.222 7.543
202303 6.777 127.348 7.013
202306 7.341 128.729 7.515
202309 7.938 129.860 8.055
202312 7.869 129.419 8.012
202403 7.997 131.776 7.997

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Surmodics  (STU:SU6) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Surmodics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Surmodics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics (STU:SU6) Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (STU:SU6) Headlines

No Headlines